Our Objectives

TRANSFORM aims to facilitate discussions between stakeholders and policy-makers, with the following objectives:

  • Collaborate in the development and dissemination of evidence-based recommendations to enable patient access to cell and gene therapies.
  • Inform MEPs about the specificities of these transformative therapies with a view to shaping policy.
  • Prepare healthcare systems for the adoption of these transformative therapies.

@TRANSFORM_CGT on Twitter Follow us →

RT @CancerPatientsE: 📣 We are calling for better use of real-world evidence to improve health outcomes! Join us and sign the Call to Action…
23 March at 4:09pm
RT @RWE4Decisions: Dr A Natz @EUCOPE shares the value of the multi-stakeholder collaboration in #RWE4Decisions and @TRANSFORM_CGT, key init…
23 March at 4:08pm
Today @ 🇪🇺 #HealthTechSummit, Dr.Natz @Eucope mentioned @TRANSFORM_CGT as a multi stakeholder platform fostering dialogue & providing recommendations on how to make the best possible use of #RWD to enable patient access to therapies ➡️see Charter Rec#3: https://t.co/XAeoSimAzh.
23 March at 4:08pm